Spirometry is really useful and feasible in the GPs' daily practice but guidelines alone are not

European Journal of General Practice

Volumn 11, Issue 1, 2005, Pages 29-31

  Sauro, Alfonso ^a,b   Scalzitti, Fausto ^b   Buono, Nicola ^a   Siringano, Rodolfo ^b   Petrazzuoli, Ferdinando ^a   Diodati, Giuseppe ^b   Canzano, Silvestro ^b   Castellano, Maria C ^b   D'Addio, Filippo ^a   Pascarella, Andrea ^b   Sortino, Domenico ^b  

^a WONCA   (Italy)

^b SNAMID ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

SALBUTAMOL;

ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DATA ANALYSIS; DIAGNOSTIC TEST; FEASIBILITY STUDY; GENERAL PRACTICE; GENERAL PRACTITIONER; HUMAN; MAJOR CLINICAL STUDY; MEDICAL EDUCATION; MEDICAL SPECIALIST; PATIENT REFERRAL; PRACTICE GUIDELINE; QUALITY CONTROL; RESPIRATORY TRACT DISEASE; SPIROMETER; SPIROMETRY; STATISTICAL SIGNIFICANCE;

EID: 20144388759     PISSN: 13814788     EISSN: None     Source Type: Journal    
DOI: 10.3109/13814780509178015     Document Type: Article

References (15)

1. National Heart, Lung, and Blood Institute/World Health Organization. Global strategy for diagnosis, management and prevention of chronic obstructive pulmonary disease. National Heart, Lung, and Blood Institute/World Health Organization workshop report. Available from www.goldcopd.com. Accessed 23 December 2002.
2. Antò JM, Vermeire P, Vestbo J, Sunyer J. Epidemiology of chronic obstructive pulmonary disease. Eur Resp J 2001;17 982-94.
3. Calverley PMA. COPD: early detection and intervention. Chest 200;117(suppl 2):S365-71.
4. Friedman M, Hilleman DE. Economic burden of chronic obstructive pulmonary disease. Impact of new treatment options. Pharmaco-economics (New Zealand) 2001;19(3):245-54.
5. Hilleman DE, Dewan N, Malesker M, Friedman M. Pharmaco-economic evaluation of COPD. Chest 2000;118(5):1278-85.
6. Dal Negro R, Rossi A, Cerveri I. The burden of COPD in Italy: results from the Confronting COPD survey. Respir Med 2003;97 Suppl C:S43-50.
7. Centers for Disease Control and Prevention. Vital and Health Statistics: Current Estimates From the National Health Interview Survey, 1996. Hyattsville, MD: US Department of Health and Human Services; 1999.
8. National Asthma Education and Prevention Program. Expert panel report: Guidelines for the diagnosis and management of asthma - update on selected topics - 2002. J Allergy Clin Immunol 2OO2; 110(5 suppl):S141-S219. Also available from www.ginasthma.com.
9. Sauro A, Petrazzuoli F, Scalzitti F, Mastroianni RA, Buono N, Diodati G. General practitioners can easily use spirometers. BMJ 2003. Letter, available from http://bmj.com/cgi/eletters/324/7350/DC1#34359, 13 July 2003.
10. Sauro A, Petrazzuoli F, Scalzitti F, Mastroianni RA, Buono N, Diodati G. Is the use of the spirometer easy and feasible in everyday GPs' practice? EGPRW (European General Practice Research Workshop) - Bled Slovenia - Abstract Book 2002. Eur J Gen Pract 2002;8:165. Also available from European General Practice Research Workshop.
11. Upton MN, Ferrel C, Bidwell C, McConnachie A, Goodfellow J, Smith DG, et al. Improving the quality of spirometry in an epidemiological study: the Renfrew Paisley (Midspain) family study. Public Health 2000;114(5):353-60.
12. Buffels J, Degryse J, Heyrman J, Decramer M. Office Spirometry Significantly Improves Early Detection of COPD in General Practice. The DIDASCO Study. Chest 2004;125:1394-9.
13. Takahashi T, Ichinose M, Inoue H, Shirato K, Hattori T, Takishima T. Underdiagnosis and undertreatment of COPD in primary care settings. Respirology 2003;8(4):504-8.
14. O'Dowd LC, Fife D, Tenhave T, Panettieri RA. Attitudes of physicians toward objective measures of airway function in asthma. Am J Med 2003;114(5):391-6.
15. Cochran WG. In: Sampling Techniques (3rd Edition). New York: Wiley; 1977.